{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T18:06:17Z","timestamp":1649095577383},"reference-count":5,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Urology"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1016\/j.eururo.2008.06.015","type":"journal-article","created":{"date-parts":[[2008,6,14]],"date-time":"2008-06-14T08:57:30Z","timestamp":1213433850000},"page":"658","source":"Crossref","is-referenced-by-count":0,"title":["Editorial Comment on: FGFR3 Mutations Indicate Better Survival in Invasive Upper Urinary Tract and Bladder Tumours"],"prefix":"10.1016","volume":"55","author":[{"given":"N\u00faria","family":"Malats","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco X.","family":"Real","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.eururo.2008.06.015_bib1","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/12615","article-title":"Frequent activating mutations of FGFR3 in human bladder and cervix carcinomas","volume":"23","author":"Cappellen","year":"1999","journal-title":"Nat Genet"},{"key":"10.1016\/j.eururo.2008.06.015_bib2","doi-asserted-by":"crossref","first-page":"3664","DOI":"10.1200\/JCO.2005.05.1771","article-title":"Prospective study of FGFR3 mutations as a prognostic factor in nonmuscle invasive urothelial bladder carcinomas","volume":"24","author":"Hern\u00e1ndez","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.eururo.2008.06.015_bib3","first-page":"244","article-title":"Mutation of the FGFR3 oncogene is an independent and favorable prognostic factor for tumor-specific survival in patients with urothelial carcinoma of the upper urinary tract","volume":"90","author":"Burger","year":"2006","journal-title":"Verh Dtsch Ges Pathol"},{"key":"10.1016\/j.eururo.2008.06.015_bib4","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.eururo.2008.06.013","article-title":"FGFR3 mutations indicate better survival in invasive upper urinary tract and bladder tumors","volume":"55","author":"van Oers","year":"2009","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2008.06.015_bib5","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S1470-2045(07)70008-6","article-title":"Bladder cancer and apoptosis: matters of life and death","volume":"8","author":"Real","year":"2007","journal-title":"Lancet Oncol"}],"container-title":["European Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283808006866?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283808006866?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,27]],"date-time":"2018-12-27T21:52:42Z","timestamp":1545947562000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0302283808006866"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":5,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["S0302283808006866"],"URL":"https:\/\/doi.org\/10.1016\/j.eururo.2008.06.015","relation":{},"ISSN":["0302-2838"],"issn-type":[{"value":"0302-2838","type":"print"}],"subject":[],"published":{"date-parts":[[2009,3]]}}}